News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Dégi László Csaba: ECO and EHA Demand Better for the Europeans Facing Blood Cancer
Dégi László Csaba/LinkedIn
Jun 9, 2025, 17:03

Dégi László Csaba: ECO and EHA Demand Better for the Europeans Facing Blood Cancer

Dégi László Csaba, President of the European Cancer Organisation, shared a post on LinkedIn about a paper by John G. Gribben et al. published in HemaSphere:

“300,000 Europeans face blood cancer diagnoses yearly, but delays, unequal access, and declining quality of life are killing too many. The European Cancer Organisation and European Hematology Association demand better: rapid tests, expert care hubs, and patient-first standards. Read more in HemaSphere.”

Title: European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological Malignancies

Authors: John G. Gribben, Leticia Quintanilla-Martinez, Simon Crompton, Jann Arends, Christophe Bardin, Heiko Becker, Frederic Castinetti, Dégi L. Csaba, Melvin D’Anastasi, Thomas Frese, Jan Geissler, Reda Matuzeviciene, Marius E. Mayerhoefer, Rui Medeiros, Kate Morgan, Šarūnas Narbutas, Samantha Nier, Umberto Ricardi, Eugenia Trigoso Arjona, Mehmet Ungan, Lorna Warwick, Emanuele Zucca.

Dégi László Csaba: ECO and EHA Demand Better for the Europeans Facing Blood Cancer

You can read the Full Article in HemaSphere.

More posts featuring Dégi László Csaba.

blood cancer cancer Christophe Bardin Dégi László Csaba Emanuele Zucca Eugenia Trigoso Arjona European Cancer Organisation European Hematology Association HemaSphere Jann Arends John G. Gribben Leticia Quintanilla-Martinez Lorna Warwick Mehmet Ungan OncoDaily Oncology Simon Crompton Umberto Ricardi
Special Coverage
Blog
Jul 19, 2025, 08:54
Jennifer Bires: Psychedelic-Assisted Therapy for Adults with Cancer
Positive
Jul 19, 2025, 07:24
Strengthening Public Health: Cyprus Donates Lifesaving Medicines to Botswana
Dialogues
Jul 19, 2025, 07:23
Empowering Oncologists: Evolving role of AI in Oncology
Drugs
Jul 19, 2025, 07:22
Datopotamab deruxtecan-dlnk (Datroway) 2025 Guides: What Patients Need to Know?
Insight
Jul 19, 2025, 07:21
Wafik El-Deiry: Collaboration in US and Global Fight Against Cancer
Drugs
Jul 19, 2025, 07:08
Datopotamab Deruxtecan-dlnk (Datroway) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and More
Blog
Jul 19, 2025, 02:39
Alisher Kahharov: Training at the Prestigious Saint-Louis Hospital in Paris
Blog
Jul 19, 2025, 02:07
Bernard A. Fox: Back in Taiwan - Sharing the Next Frontier in Cancer Immunotherapy at Grand Rounds
Blog
Jul 19, 2025, 02:00
Akash Maniam: How Best to De-Escalate Excellent Responders and Intensify Those Who Don't
Career
Jul 18, 2025, 22:12
Sosipatros Boikos Joins the Life Raft Group As An External Consultant Medical Oncologist
Blog
Jul 18, 2025, 21:37
Zeynep Irem Ozay: Presentation by Ruchi Agarwal on Global Disparities in Clinical Trial Availability for Renal Cell Carcinoma
Insight
Jul 18, 2025, 21:36
Major disparities in access to Molecular Tumour Boards - Lung Cancer Europe